feed

Article: CME Group to Acquire NEX Group plc, Details and PDF

29 March 2018 | CME Feed
 

How does this change the independance of services within NEX such as TriOptima? TriOptima currently provides optimisation services in the cleared and uncleared markets to firms like LCH. LCH has other compression partners, is that an opportunity for others to take market share from TriOptima as it will now be aligned with CME? Full PDF on the transaction attached below.


CME Group Inc. (Nasdaq: CME) and NEX Group plc (NXG.L) today announced that they have reached an agreement in which CME Group will acquire NEX in a transaction valued at £10 per share, consisting of 500 pence in cash and 0.0444 CME Group shares (based on CME's closing share price of US$158.84 on March 28, 2018 and the exchange rate of US$1.4101:£1, on March 28, 2018).  The proposed transaction has been approved unanimously by the board of directors of both companies and is expected to close, pending approvals by regulators and NEX shareholders, in the second half of 2018.

This acquisition brings together two trading-industry trailblazers to create a leading, client-centric, global markets company that will deliver better ways to trade and manage risk across futures, cash and OTC products.

Combining NEX's leading electronic FX and fixed income cash execution platforms with CME Group will improve trading technology and streamline access by reducing the number of touchpoints that clients need to trade across products.  In addition, NEX's premier OTC post-trade products and services complement CME Group's derivatives clearing services.  Combining these solutions will strengthen the NEX compression, reconciliation and processing businesses.  The combination will also facilitate the development of innovative post-trade services and data offerings to further enhance cost-effective trading and risk management.

"At a time when market participants are seeking ways to lower trading costs and manage risk more effectively, this acquisition will allow us to create significant value and efficiencies for our clients globally," said CME Group Chairman and Chief Executive Officer Terry Duffy.  "As one organization, we will be able to employ the complementary strengths of each company to serve a wider client base while diversifying our combined businesses across futures, cash and OTC products and post-trade services."

"Michael Spencer and his senior leadership team have built a world-class organization that is at the center of capital markets. We are committed to maintaining the longstanding relationships NEX has with its clients, and exchange and clearing house partners.  Building on NEX's deep roots in Europe and Asia and CME's strong technology platform, we will transform our international profile and broaden our distribution network in spot and futures FX products as well as cash, repo and futures products in U.S. Treasuries," Duffy said.

Following completion of the acquisition, NEX CEO Michael Spencer will join the CME Group Board of Directors. He will remain with the combined company as a Special Adviser, working to drive the integration and continued evolution of the NEX businesses.   He also will be ambassador for the combined company, working with key clients, regulators and officials in EMEA and Asia.

Spencer said, "The combination of NEX and CME will be an industry-changing transaction.  Bringing together cash and futures products and OTC services will be unique, offering clients improved access to trading, greater financial efficiencies and highly valuable data sets.  The technology and innovation opportunities will be diverse and extraordinary.  Clients will be better served."

"CME's decision to choose London as its European headquarters is also a signal of tremendous support for Britain'sfinancial services sector," Spencer said.

Client Benefits – The transaction enhances trading and post-trading services for clients globally:

  • Delivers streamlined access and new trading opportunities across cash, futures and OTC marketplaces.
  • Enables valuable new efficiencies and risk mitigation services through clearing and post-trade services across listed, cleared OTC and bilateral OTC marketplaces.
  • Creates timely, new fixed income opportunities as clients look to manage risk as the Fed unwinds its balance sheet and the U.S. budget deficit grows.
  • Delivers new trading opportunities in an FX marketplace experiencing strong tailwinds, including global GDP growth, the return of volatility, and the continuing electronification of FX trading globally.
  • Maintains BrokerTec clearing at FICC, with a goal to increase capital efficiencies for customers.
  • Offers improved functionality and performance, combining NEX businesses with CME Group's proven technology infrastructure.
  • Scales and streamlines NEX's leading compression, reconciliation and processing services.
  • Expands market data offerings.

Growth Opportunities – The transaction is strategically attractive and financially compelling:

  • Expands CME Group's FX business beyond futures to spot products, and broadens Treasury offering to include cash products.
  • Allows CME to introduce futures to the broad NEX user base, particularly in FX trading.
  • Increases international footprint and expands sales team and relationship-based trading capabilities.
  • Offers solutions for the full post-trade value chain, and creates opportunities to develop new products and services to address the continuing impact of uncleared margin rules.
  • Adds recurring, subscription-based revenue to CME Group transaction-based revenue model.